戻る Agenda
Enabling Translation of Research and Innovation into Regulatory Standards
Session Chair(s)
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator
Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Presentations regarding Horizon EU, current and future public private partnership funding, its successes and challenges, and the European Institute of Innovation and Technology will be discussed with practical examples to illustrate key learnings.
Learning Objective : In this session, participants will: • develop an understanding of current opportunities to ensure innovative medicine development and regulatory standards are in sync • learn how current&future European initiatives to support innovation (beyond medicine alone) are designed for maximum impact • be invited to contribute practical ideas to ensure innovation translates into regulatory standards
Speaker(s)
A presentation by the European Medicines Agency that outlines examples of how this organisation supports the translation of medicines innovation into regulatory standards and, based on these examples, highlights key factors for success.
Tony Humphreys, MPHARM
European Medicines Agency, Netherlands
Head of the Regulatory Science and Innovation Task Force
Examples of case studies from public-private partnerships that have impacted regulatory standards, with learnings about hurdles and success factors presented from the private as well as the public project participants’ perspective
Pierre Meulien, PHD
Innovative Medicines Initiative (IMI), Belgium
Executive Director
An overview of medicines innovation support foreseen under Horizon EU, including current plans for, and expectations from, cross-disciplinary public private partnership funding mechanisms – presented by DG-RTD
Irene Norstedt
European Commission, Belgium
Director - People Directorate, DG Research and Innovation